Biospectrumindia

A research team from Pohang University of Science and Technology (POSTECH), in , has engineered an artificial kidney that allows for the early detection of adverse drug reactions.

Korea designs artificial kidney for early detection of drug toxicity Korea designs artificial kidney for early detection of drug toxicity

Speaking on the sidelines of the recently held mega event, the 14th National Conference of AIDS Society of India (ASICON), Dr Ishwar Gilada, President, AIDS Society of India (ASI) and Governing Council member of International AIDS Society (IAS), said, "Indian pharma's capacity to produce generic antiretrovirals and supply them globally had resulted in major successes for Acquired Immunodeficiency Syndrome (AIDS) fight worldwide as 92 per cent of Human Immuno-Deficiency Virus (HIV) medicines are from Indian pharma companies".

"We should immediately eliminate Mother to Child transmission of HIV": Dr Ishwar Gilada, President, ASI The AIDS Society of India (ASI) is a nation-wide network of HIV medical experts and researchers

World Health Organization has announced the expanded scope of the WHO Director-General’s (DG) Flagship Initiative on (TB) over the period from 2023 to 2027 to support fast-tracking progress towards ending TB and achieving Universal Health Coverage (UHC) by 2030.

WHO steps up Director-General’s flagship initiative to combat tuberculosis The initiative highlights the pressing need to increase both domestic and international investments in TB services, research, and innovation

Axio Biosolutions, a Bengaluru-based focused medtech company, has announced the US FDA 510(k) clearance for its latest innovation, AxSurgi Surgical Hemostat. With this, Ax-surgi has become the first and only chitosan based hemostat cleared for controlling severe surgical bleeding.

Axio Biosolutions announces US FDA clearance for Ax-Surgi Surgical Hemostat Ax-surgi is a ready to use, non-absorbable hemostat